Preimplantation genetic testing (PGT) for monogenic disorders
PURPOSE OF PROGRAMME:
Analysis and interpretation of monogenic disorders in the PGT setting: DNA for molecular studies.
MATERIAL PROVIDED: Cells, DNA in TE buffer
DISTRIBUTIONS PER YEAR: 2
SAMPLES PER DISTRIBUTION: 2
FREQUENCY OF DISTRIBUTION: 2 within 1 month
PROGRAMME OF ANALYSIS:
Stage 1: DNA feasibility study. Stage 2: Embryo testing.
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA